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 78 year old black female with history of invasive ductal 
carcinoma in left breast status post lumpectomy and 
cytotoxic chemotherapy
 Patient developed acute onset bullae on left breast during 
24th cycle of radiation therapy (RT) and which was 
diagnosed as radiation dermatitis by her radiation 
oncologist
 Patient continued to develop new tense bullae on the left 
breast after cessation of RT
 Within 4 weeks, patient was hospitalized with dysphagia, 
odynophagia and oropharyngeal ulcerations
 At 8 weeks, patient developed new tense bullae on 
extremities and presented to dermatology
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DISCUSSION
 Radiation dermatitis is not always the answer
o Persistent development of bullae after cessation of RT 
and spread of bullae to areas outside the area of RT 
indicate need for further work up
 Radiation induced bullous pemphigoid
o Rare complication of RT
o Most commonly seen in patients with breast cancer but 
has been associated with lung, vulvar and esophageal 
carcinomas
o Cases commonly occur at the time of RT or up to 6 
months after cessation of RT
o Majority of cases remain localized to RT-treated areas, 
and rarely is there involvement of oral mucosa
o Appears more indolent than non-RT BP and may respond 
to topical and oral corticosteroids
 Proposed etiologies
o Breast cancer cells express a mixture of 
hemidesmosomes, similar to those found in the 
basement membrane
o Release of cell contents following RT could serve as an 
antigen for immune cells and lead to production of BP 
autoantibodies
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 Entirety of left breast exhibited multiple tense 
serosanguinous filled bullae and erosions (Figure 1)
 Bullae were interspersed by well-demarcated depigmented 
patches with perifollicular macules of repigmentation
 Three tense serosanguinous bullae were present on the 
right lower extremity and left ankle
 Two linear erythematous erosions with mild fibrinous debris 
extended from the hard palate down the oropharynx 
(Figure 2)
 Nikolsky sign was negative
Figure 1.
Multiple tense 
serosanguinous 
filled bullae and 
erosions 
involving the left 
breast.
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Figure 2.
Linear erythematous 
erosions with mild 
fibrinous debris 
extending from the 
hard palate down the 
oropharynx.
 H&E of punch biopsy from right medial thigh
o Separation at the dermal epidermal junction, resulting in 
subepidermal blister with sparse infiltrate of lymphocytes 
and eosinophils in the underlying dermis
 Direct immunofluorescence
o IgG and C3 with 3+ linear staining at the basement 
membrane zone
 Salt split skin analysis
o Localization of IgG and C3 in a linear pattern to the 
epidermal side of dermal-epidermal junction
PATHOLOGY
 High potency topical corticosteroids
 Oral prednisone taper with improvement
 Doxycycline 100 mg BID with niacinamide 500 mg BID
 Patient continued to improve with new vesicles and 
bullae responsive to topical corticosteroids
 Proposed next step is dapsone to avoid 
immunosuppression
TREATMENT
